Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -76.07% is 29% below its 5-year average of -58.81%, near the low end of its 5-year range (-96.52%–-20.52%).
As of the fiscal period ended Tuesday, June 30, 2026. 2.39% below its 12-month average of -74.29%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -76.07%.
RETURN ON EQUITY (ROE)
-76.07%
RETURN ON EQUITY (ROE) AVG TTM
-74.29%
RETURN ON EQUITY (ROE) AVG 3Y
-66.48%
RETURN ON EQUITY (ROE) AVG 5Y
-58.81%
RETURN ON EQUITY (ROE) AVG 10Y
-73.54%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-2.39%
CURRENT VS 3Y AVG
-14.43%
CURRENT VS 5Y AVG
-29.35%
CURRENT VS 10Y AVG
-3.44%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.20%
median of 638 covered companies
CURRENT VS SECTOR MEDIAN
-89.21%
vs the sector median at left
enVVeno Medical Corporation
Market Cap
$5.60M
Return on Equity (ROE)
-76.07%
TTM Avg
-74.29%
3Y Avg
-66.48%
5Y Avg
-58.81%
Market Cap
$5.63M
Return on Equity (ROE)
-92.08%
TTM Avg
-1221.97%
3Y Avg
-730.41%
5Y Avg
-532.44%
Market Cap
$5.77M
Return on Equity (ROE)
-92.44%
TTM Avg
-28.72%
3Y Avg
10.69%
5Y Avg
23.75%
Market Cap
$5.85M
Return on Equity (ROE)
-111.42%
TTM Avg
-84.56%
3Y Avg
-107.54%
5Y Avg
-308.31%
Market Cap
$6.10M
Return on Equity (ROE)
-59.21%
TTM Avg
-23.87%
3Y Avg
-948.19%
5Y Avg
-660.49%
Market Cap
$5.21M
Return on Equity (ROE)
-156.77%
TTM Avg
-655.11%
3Y Avg
-353.82%
5Y Avg
-293.10%
Market Cap
$5.24M
Return on Equity (ROE)
-225.57%
TTM Avg
-289.16%
3Y Avg
-245.03%
5Y Avg
-192.04%
Market Cap
$5.24M
Return on Equity (ROE)
-156.94%
TTM Avg
-121.17%
3Y Avg
-95.34%
5Y Avg
-84.55%
Market Cap
$5.24M
Return on Equity (ROE)
-42.05%
TTM Avg
-32.76%
3Y Avg
-25.11%
5Y Avg
-45.26%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| enVVeno Medical Corporation (NVNO) | $5.60M | -76.07% | -74.29% | -66.48% | -58.81% |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | -92.08% | -1221.97% | -730.41% | -532.44% |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.77M | -92.44% | -28.72% | 10.69% | 23.75% |
| Lucyd, Inc (LUCY)vs › | $5.85M | -111.42% | -84.56% | -107.54% | -308.31% |
| Scienture Holdings, Inc. (SCNX)vs › | $6.10M | -59.21% | -23.87% | -948.19% | -660.49% |
| Alzamend Neuro Inc (ALZN)vs › | $5.21M | -156.77% | -655.11% | -353.82% | -293.10% |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.24M | -225.57% | -289.16% | -245.03% | -192.04% |
| Pulmatrix, Inc. (PULM)vs › | $5.24M | -156.94% | -121.17% | -95.34% | -84.55% |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.24M | -42.05% | -32.76% | -25.11% | -45.26% |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.91M | 105.35% | 0.10% | -37.77% | -33.57% |
ROE
-76.1%
ROA
-69.4%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -76.07% |
| 2026-03-31 | -79.24% |
| 2025-12-31 | -71.77% |
| 2025-09-30 | -74.59% |
| 2025-06-30 | -69.78% |
| 2025-03-31 | -55.68% |
| 2024-12-31 | -51.75% |
| 2024-09-30 | -44.84% |
| 2024-06-30 | -53.62% |
| 2024-03-31 | -52.20% |
| 2023-12-31 | -50.90% |
| 2023-09-30 | -96.52% |
| 2023-06-30 | -87.27% |
| 2023-03-31 | -75.39% |
| 2022-12-31 | -63.70% |
| 2022-09-30 | -64.39% |
| 2022-06-30 | -51.05% |
| 2022-03-31 | -37.19% |
| 2021-12-31 | -30.38% |
| 2021-09-30 | -20.52% |
| 2021-06-30 | -28.13% |
| 2021-03-31 | -24.99% |
| 2020-12-31 | -128.71% |
| 2020-09-30 | -147.08% |
| 2019-12-31 | -770.29% |
| 2019-09-30 | -230.75% |
| 2019-06-30 | -145.52% |
| 2019-03-31 | -344.46% |
| 2018-12-31 | -640.47% |
| 2018-09-30 | -406.08% |
| 2018-06-30 | -329.06% |
| 2016-09-30 | -754.89% |
